Blue Matter’s Post

Swiss Biotech Day is just around the corner 👍 The platform with professionals in the life sciences community ✅ ... for networking, engaging discussions, exploring progresses in research, manufacturing, data, financing ✅ ... you name it ✅ Swiss Biotech Association #swissbiotechday  #swissbiotechday2024

ARENSIA Exploratory Medicine GmbH early phase clinical InnovationXChange Europe is happening on the 16 April at the prestigious Dolder Grand Zurich Hotel. This summit will bring together more than 30 senior-level executives from some of the most innovative Pharmaceutical and Biotech companies in Europe with many thanks to our confirmed speakers and thought leaders including: - Ingeborg Heirman - Senior Director Clinical Trial Operations - Regeneron - Ulf Grawunder - CEO - T-CURX GmbH - Laura Lassouw-Polman - COO - Sairopa B.V. - Nick Clark - Executive Director Regulatory Affairs - Gilead - Inge De Clercq - Clinical Operations Development Lead - argenx - Dr. Claudia Hesselmann, PhD - CEO - ARENSIA Exploratory Medicine GmbH - Alina Jucov - Medical Director - ARENSIA Exploratory Medicine GmbH If you represent Pharma or Biotech and have an active drug developing pipeline and would like to attend drop me a line as we are close to capacity. #arensia #earlyphase #clinicaldevelopment #oncology #cns #immunology #diversity #equity #inclusion #patientrecruitment #siteactivation

[𝗔 𝗻𝗲𝘄 𝗽𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁 𝗳𝗼𝗿 𝗙𝗲𝗱𝗲𝗿𝗮𝘁𝗲𝗱 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 @𝗠𝗜𝗡𝗗] 👉Fabrizio Grillo, Bracco's 𝗗𝗶𝗿𝗲𝗰𝘁𝗼𝗿 𝗼𝗳 𝗣𝘂𝗯𝗹𝗶𝗰 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 & 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗥𝗲𝗹𝗮𝘁𝗶𝗼𝗻𝘀, highlights the advancement of the Network and the fostering of dialogue between the public and private sectors in his inaugural statements as the newly appointed President of Federated Innovation @MIND. 🔗Find out more in the article published by AboutPharma : https://lnkd.in/dgJB7GPv

If you are planning to make it out to San Francisco next week for the JPM Biotech Showcase 2024, please do send me a note to my email at [email protected] and we would be happy to schedule a time to meet with you and tell you more about PharPoints industry leading timelines (Database ready for sponsor - 15 days after final protocol received) and how we have been able to enroll recent studies well AHEAD of schedule! We look forward to seeing everyone there! #clinicalresearch #clinicaltrials #clinical #pharma #pharmaceutical #biostatistics #biotech #biotechnology #datamanagement

Last call for early bird savings: 24th BioEquity Europe. ✅ Register (or apply to present) by Friday, Feb. 9 to save: https://lnkd.in/gSxxhu7 What is Bio€quity? 🔹 Bio€quity Europe is a destination event for VCs and biopharma decision-makers. 🔹 This year we will gather in San Sebastián, Spain, Basque Country, to discuss how biotechs can rise above the noise to attract the right investors, partners, and talent. Why attend? ➣ Debate how to stand out from the crowd and reach the discussion stage with investors and #pharma. ➣ Meet VCs, CEOs, and BD&L leaders in an intimate setting designed for networking and discussion. ➣ Discover 100+ emerging biotechs selected for the Presenting Company Track. ➣ Dive into European biotech trends with an exclusive conference report from Insights Partner McKinsey & Company. ➣ Build stronger connections with investors and CEOs during the pre-event networking excursions – pintxos tour, wine tasting, golf, and more.  ➣ Schedule one-to-one meetings; check out the Poster Session; take your conversation outside, onto the beach. Don't wait to register. Last year, BioEquity sold out. I hope to see you there! P.S. On behalf of BioCentury Inc. and EBD Group, many thanks to everyone supporting the event, including Regional Host Chair Ysios Capital; Founding Sponsor Sofinnova Partners; Talent Showcase Sponsor Johnson & Johnson; R&D Sponsor ICON plc + Bioqube Ventures, Syncona Limited , UCB Ventures, VIB and many more. #venturecapital #biotech #biopharma #drugdevelopment #businessdevelopment

At the meeting of our Healthcare Steering Committee with the ENEA Tech e Biomedical Foundation, we discussed the framework conditions for increasing investment in research and innovation in the biomedical and life sciences sector. As Camera di Commercio Italo-Germanica (AHK Italien) we represent around 15% of the Italian healthcare sector and with our companies we want to make a contribution to strengthening the Italian healthcare system. Our community of over 1,700 German companies in Italy is already the largest green field investor in Italy. In the current transformation scenario, the stimulation of investments and the promotion of innovative projects is of central importance for Italy and Germany, two very important countries for the resilience of Europe and the competitiveness of its production systems.

As BIO-Europe kicks off today in Munich, we're making our debut with our crisp new branding. 🌟   How does BIO-Europe differ from the BIO International Convention set for June in San Diego?   Many assume that one is merely the European counterpart of the U.S. event. While both are indeed fantastic partnering events, each hosting between 25,000 and 50,000 one-on-one meetings and paving the way for transformative partnerships, they have distinct backstories.   The popular BIO Int'l convention is organized by BIO.org, a not-for-profit entity. That means when you buy a BIO San Diego ticket, you're not just gaining access, you're also supporting BIO’s advocacy efforts for the broader biotech industry.   Not to mention that BIO's One-on-One, award-winning matchmaking solution, runs on Inpart Event 😊. If you use our partnering CRM, Deal, your meetings in San Diego will be seamlessly synced. But here's the good news for those attending BIO-Europe and using our partnering CRM: you can easily import your meetings using a straightforward export/import feature we've recently introduced.

⭕ Round table during #Horizon4Poland 2023 - The largest matchmaking event in the R&D sector in Poland 📅 Coming on November 2️⃣ 1️⃣ st 📍 Fabryka Norblina 👆 We'll discuss about IHI program - including public private partnership perspective. An open discussion led by Magdalena Kulczycka,Ph.D., Director of Central European BioForum, and Magali Poinot Team Leader of the Governance Cell at Innovative Health Initiative (IHI), will help answer questions such as: ✅ What SMEs need from the IHI program?  ✅ What obstacles do they have when applying to programs?   ✅ What are the benefits for SMEs ?  ✅ How big pharma companies see the benefits from IHI programs - for them/ for the ecosystem?  ✅ How IHI programs can stimulate the biotech ecosystem ?  ✅ How IHI programs stimulate the European ecosystem on a global scale? Interested ❓ Join us during the event ➡ https://lnkd.in/dkbRP5Kv Anna Kacprzyk, Monika Ślęzak, Katarzyna Banyś, Igor Deryło #HoryzontEuropa, #science, #business, #cooperation